ArticleOncotarget2016

Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.

Nikolas M Eleftheriou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.